Protein tyrosine phosphatase receptor type Z (PTPRZ) maintains oligodendrocyte precursor cells (OPCs) in an undifferentiated state. The inhibition of PTPase by its ligand pleiotrophin (PTN) promotes OPC differentiation; however, the substrate molecules of PTPRZ involved in the differentiation have not yet been elucidated in detail. We herein demonstrated that the tyrosine phosphorylation of AFAP1L2, paxillin, ERBB4, GIT1, p190RhoGAP, and NYAP2 was enhanced in OPC-like OL1 cells by a treatment with PTN. AFAP1L2, an adaptor protein involved in the PI3K-AKT pathway, exhibited the strongest response to PTN. PTPRZ dephosphorylated AFAP1L2 at tyrosine residues in vitro and in HEK293T cells. In OL1 cells, the knockdown of AFAP1L2 or application of a PI3K inhibitor suppressed cell differentiation as well as the PTN-induced phosphorylation of AKT and mTOR. We generated a knock-in mouse harboring a catalytically inactive Cys to Ser (CS) mutation in the PTPase domain. The phosphorylation levels of AFAP1L2, AKT, and mTOR were higher, and the expression of oligodendrocyte markers, including myelin basic protein (MBP) and myelin regulatory factor (MYRF), was stronger in CS knock-in brains than in wild-type brains on postnatal day 10; however, these differences mostly disappeared in the adult stage. Adult CS knock-in mice exhibited earlier remyelination after cuprizone-induced demyelination through the accelerated differentiation of OPCs. These phenotypes in CS knock-in mice were similar to those in Ptprz-deficient mice. Therefore, we conclude that the PTN-PTPRZ signal stimulates OPC differentiation partly by enhancing the tyrosine phosphorylation of AFAP1L2 in order to activate the PI3K-AKT pathway.
| INTRODUCTION
The myelination of axonal fibers provides electrical insulation to axons, which facilitates the transmission of nerve impulses, and functions to maintain long-term axonal integrity (Funfschilling et al., 2012; Griffiths et al., 1998; Lee et al., 2012) . In the central nervous system (CNS), oligodendrocyte precursor cells (OPCs) are the principal source of oligodendrocytes for the formation of myelin sheaths during development and in the remyelination of demyelinated axons in adulthood (Buffo & Rossi, 2013) . The protein tyrosine phosphorylation of various signaling molecules, which is reversibly regulated by protein tyrosine kinases (PTKs) and protein tyrosine phosphatases (PTPs), is crucial for regulating OPC differentiation to oligodendrocytes (Kramer-Albers & White, 2011) . FYN tyrosine kinase, a SRC family PTK, is the most prominent member for OPC differentiation and myelination (KramerAlbers & White, 2011; Lu, Ku, Chen, & Feng, 2005) . FYN activation drives OPC differentiation by coordinately regulating several downstream pathways, including the Rho-ROCK (Kramer-Albers & White, 2011) , MEK-ERK (Colognato, Ramachandrappa, Olsen, & ffrenchConstant, 2004; Perez, Fernandez, & Pasquini, 2013; Xie et al., 2016) , phosphoinositide 3-kinase (PI3K)-AKT, and mammalian target of rapamycin (mTOR) (Colognato et al., 2004; Flores et al., 2008; Goebbels et al., 2010; Tyler et al., 2009) pathways. Consequently, Fyn-deficient mice show hypomyelination in the brain (Cui, Zheng, Quirion, & Almazan, 2005; Umemori et al., 1999) .
In contrast, protein tyrosine phosphatase receptor type Z (PTPRZ, also called PTPζ), one of the most abundant PTPs in OPCs (Ranjan & Hudson, 1996; Sim et al., 2006) , functions to maintain OPCs in an undifferentiated state Kuboyama et al., 2012; Kuboyama, Fujikawa, Suzuki, Tanga, & Noda, 2016; Kuboyama, Tanga, Suzuki, Fujikawa, & Noda, 2017) . Two transmembrane isoforms, PTPRZ-A and PTPRZ-B, and one secretory isoform, PTPRZ-S (also known as phosphacan or 6B4 proteoglycan) corresponding to the extracellular portion of PTPRZ-A, are generated from a single PTPRZ gene by alternative splicing (Chow, Fujikawa, Shimizu, Suzuki, & Noda, 2008; Krueger & Saito, 1992; Levy et al., 1993; Maeda, Hamanaka, Shintani, Nishiwaki, & Noda, 1994) . The three isoforms expressed in the CNS belong to chondroitin sulfate proteoglycans (CSPGs) because they are highly glycosylated by chondroitin sulfate chains Nishiwaki, Maeda, & Noda, 1998) . The chondroitin sulfate moiety is required for the high-affinity binding of endogenous ligands, such as pleiotrophin (PTN), midkine, and interleukin-34 (Kuboyama et al., 2016; Maeda et al., 1999; Maeda, Nishiwaki, Shintani, Hamanaka, & Noda, 1996; Nandi et al., 2013) .
These three ligands enhance OPC differentiation in primary glial cell cultures in vitro (Kuboyama et al., 2016) by inactivating the intracellular PTPase activity of PTPRZ (Fukada, Kawachi, Fujikawa, & Noda, 2005; Kuboyama et al., 2016; Maeda et al., 1996) .
In developing mouse brains, the expression of the PTPRZ-A isoform peaks on approximately postnatal days 5 to 10 (P5 to P10), and the maximal expression of PTN occurs on P10, corresponding to the onset of myelination, whereas midkine and interleukin-34 are maintained at constant levels from the neonatal to adult stages (Kuboyama et al., 2016) . Ptprz-deficient mice show the earlier onset of the expression of myelin basic protein (MBP), a major component of the myelin sheath, than wild-type mice (Kuboyama et al., 2012) ; inversely, Ptn-deficient mice exhibit the later onset of MBP expression (Kuboyama et al., 2016) . These findings indicate that the ligandreceptor pair of PTN-PTPRZ-A affects the timing of OPC differentiation in the developing brain (Kuboyama et al., 2016) . The p190RhoGAP-Rho-ROCK pathway has been identified downstream of PTPRZ for OPC differentiation (Kuboyama et al., 2012; Kuboyama et al., 2015; Kuboyama et al., 2016) .
To date, we have identified a number of physiological substrate molecules for PTPRZ, including p190RhoGAP Kuboyama et al., 2012; Tamura, Fukada, Fujikawa, & Noda, 2006) , G protein-coupled receptor kinase-interactor 1 (GIT1) (Fujikawa et al., 2011; Kawachi, Fujikawa, Maeda, & Noda, 2001) , paxillin (Fujikawa et al., 2011; Muramatsu et al., 2004) , membrane-associated guanylate kinase, WW and PDZ domain-containing 1 (MAGI1) , ERBB4 (Fujikawa et al., 2007) , and TrkA (Shintani & Noda, 2008) . In these substrate molecules, the amino acid sequences of the typical dephosphorylation site by PTPRZ are conserved (Fujikawa et al., 2011) . Consequently, other substrate candidates have been suggested by our previous database search (Fujikawa et al., 2011) , such as actin filament-associated protein 1-like 2 (AFAP1L2/XB130), neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2 (NYAP2), ubiquitin protein ligase E3 component n-recognin 3 (UBR3), and tight junction protein 2 (TJP2/ZO-2).
In the present study, in order to completely elucidate the PTN-PTPRZ signaling mechanisms involved in OPC differentiation, we examined the effects of a PTN stimulation on the tyrosine phosphorylation levels of substrates and substrate candidates using OL1 cells.
OL1 cells, which were established from a p53-deficient newborn mouse brain in our laboratory , are a homogenous population of OPC-like cells that are positive for neural/glial antigen 2 (NG2, an OPC marker). In the cell-based assay, AFAP1L2 exhibited the greatest increase in tyrosine phosphorylation following the PTN treatment. AFAP1L2, an adaptor protein of 130 kDa, is associated with the p85 α subunit of PI3K through the phosphorylation at Tyr-54, thereby activating the PI3K-AKT pathway without altering ERK1/2 phosphorylation (Lodyga et al., 2009; Yamanaka et al., 2012) .
We revealed that AFAP1L2 was one of the bona fide substrates for PTPRZ, and coupled the PTN-PTPRZ signal to the PI3K-AKT-mTOR pathway for OPC differentiation. We also verified the in vivo relevance of these results by generating knock-in mice carrying a catalytically inactive Cys to Ser mutation in the Ptprz gene.
| MATERIALS AND METHODS

| Ethics statement and experimental animals
All experimental animal protocols used in the present study were approved by the Institutional Animal Care and Use Committee of the National Institutes of Natural Sciences (approval numbers: 15A096, 16A145, and 16A148) and RIKEN Kobe Branch (approval number:
A2001-03-72), Japan. Ptprz-deficient mice (Shintani, Watanabe, Maeda, & Noda, 1998) and Ptprz-CS mice (see later) were backcrossed with the inbred C57BL/6J strain (CLEA Japan, Tokyo, Japan) for more than 10 generations. Mice were housed under specific pathogen-free (SPF) conditions at a constant room temperature (23 C) and 50-55% humidity with a 8:00 to 20:00 light cycle. Four to five weeks after birth, three to four sex-matched mice were housed in plastic cages (cage size: 12 × 21 × 12.5 cm) with paper-chip bedding, and food and water were provided ad libitum. Adult male mice (2 to 4 months old) and juvenile mice (< postnatal 30 days, gender unknown) were used in the present study. Mice were handled gently to minimize stress and were quickly decapitated without anesthesia to obtain tissue samples for biochemical analyses in this study. Paraformaldehyde fixation was performed under isoflurane anesthesia.
| Primary antibodies
Rabbit polyclonal antibodies against the extracellular region of PTPRZ (anti-PTPRZ-S) (Fujikawa et al., 2011) , and rabbit antibodies against phosphorylated Tyr-1,105 of p190RhoGAP (anti-pY1105) (Tamura et al., 2006) and Tyr-554 of GIT1 (anti-pY554) (Fujikawa et al., 2011) were described previously. 
| Mammalian expression plasmids and siRNAs
The mammalian expression plasmids, pZeoPTPζ for PTPRZ-B (Kawachi et al., 2001 ) and pZeoPTPζ-CS for its phosphatase-inactive CS mutant (Fujikawa et al., 2011) , were described previously. pCAG-EGFPPtprzICR-WT, -CS, -DA, and -CS mutants for the expression of EGFPfused PTPRZ-ICR proteins (the wild type and its mutants) were generated by an in-frame insertion of its corresponding cDNA into the pCAG vector (Niwa, Yamamura, & Miyazaki, 1991) . The construct pFLAG-AFAP1L2 for FLAG-tagged AFAP1L2 was generated by inserting the full-length cDNA of mouse AFAP1L2 (GenBank accession no. NM_001177797) into the pcDNA-FLAG vector . pMyc-p85α for the MYC-tagged p85α construct was generated by inserting the full-length cDNA of mouse p85α (phosphoinositide-3-kinase regulatory subunit 1, GenBank accession no. NM_001077495)
into the pcDNA vector. cDNAs were prepared by RT-PCR from mouse brain total RNA. The expression constructs for the AFAP1L2 mutant proteins were generated from their parent plasmids using a QuikChange Multisite-directed Mutagenesis kit (Stratagene, San Diego, CA).
siRNAs were ordered and purchased from Nippongene, Tokyo, Japan.
The AFAP1L2 sequences of siRNAs used were as follows: sense, 5 0 -
was used as a negative control.
2.4 | v-src-HEK293T cell culture and DNA transfection v-src-HEK293T cells stably expressing v-Src were developed and maintained in our laboratory (Fujikawa et al., 2011 2.5 | OL1 cell culture and siRNA transfection
The preparation of mouse oligodendrocyte-lineage OL1 cells was described previously 
| Immunoprecipitation and rhotekin pull-down assays
After precleaning the extracts with Protein G-Sepharose (GE Healthcare, Chicago, IL), samples were subjected to immunoprecipitation using a combination of antibodies and Protein G-Sepharose beads. Active GTP-bound RhoA was precipitated from cell extracts using Rhotekin-RBD beads in a RhoA Pull-down Activation Assay Biochem Kit (cat #BK036, Cytoskeleton, Denver, CO).
| In vitro PTPase assay
Recombinant human PTPRZ1 enzyme proteins (the whole intracellular region of human PTPRZ1) were prepared as previously described . FLAG-tagged AFAP1L2
proteins expressed in v-src-HEK293T cells were immunoprecipitated using anti-FLAG beads. The immunocomplex on beads was washed, and bound proteins were solubilized in assay buffer (50 mM Tris, 50 mM Bis-Tris, and 100 mM acetate, pH 6.5, containing 100 μg/ml BSA, 5 mM DTT, and 0.1% Tween 20) . The enzymatic reaction was initiated by adding appropriate amounts of recombinant PTP proteins with or without SCB4380, a PTPRZ inhibitor , and incubating at 37 C for 5 min. The reaction was terminated by rapid dilution and washing with ice-cold TBS containing 1 mM vanadate. The tyrosine phosphorylation of AFAP1L2 proteins was then analyzed by Western blotting.
| Western blotting
Protein samples, such as cell or tissue extracts, immunocomplexes precipitated with Protein G-Sepharose, and RhoA precipitated with Rhotekin beads were separated on a 5 to 20% gradient gel (cat # E-R520L, ATTO
Bioscience & Technology, Tokyo, Japan) by SDS-PAGE, followed by semidry electroblotting onto a PVDF membrane (Immobilon-P, Millipore).
After blocking with 4% nonfat dry milk and 0.1% Triton X-100 in TBS, the membranes were incubated overnight with the respective antibodies.
Regarding the probing of tyrosine phosphorylated proteins, 1% BSA and 0.1% Triton X-100 in TBS were used as blocking solution, with which antibodies were diluted. The binding of these antibodies was visualized with respective secondary horseradish peroxidase (HRP)-conjugated antibodies (GE Healthcare) and a chemiluminescent substrate (Luminata forte western HRP substrate, Millipore), and detected using a CCD video camera system (Ez-capture MG, ATTO Bioscience & Technology).
| Immunocytofluorescence cell staining
Cells were fixed with 4% paraformaldehyde in PBS (4.3 mM Na 2 HPO 4 , 1.4 mM KH 2 PO 4 , 137 mM NaCl, and 2.7 mM KCl at pH 7.4) for 30 min. Germany).
| Terminal deoxyribonucleotidyl transferase (TDT)-mediated dUTP-digoxigenin nick end labeling (TUNEL) assay
In apoptosis assays, siRNAs were cotransfected with an mCherry expression plasmid (Fujikawa, Matsumoto, Kuboyama, Suzuki, & Noda, 2015) to identify transfected cells. Apoptotic cells were identified using a TUNEL in situ apoptosis detection kit (Takara Bio, Shiga, Japan) according to the manufacturer's instructions. Fluorescein (FITC)-labeled dUTP and mCherry signals were observed and photographed under a fluorescence microscope (Biozero BZ-8000, Keyence, Osaka, Japan).
| Cell proliferation assay
The proliferation of OL1 cells was assessed by quantifying the incorporation of 5 0 -bromo-2-deoxyuridine (BrdU) using the cell proliferation ELISA BrdU kit (Roche) according to the manufacturer's instructions.
BrdU incorporation was evaluated using a HRP-conjugated anti-BrdU antibody with tetramethylbenzidine (TMB) substrate. The absorbance of oxidized TMB was measured at 450 nm using a spectrofluorometer (FI-4500, Hitachi, Tokyo, Japan).
| Generation of the knock-in mouse
A Ptprz Cys1930 to Ser (CS) knock-in mouse (Accession No. CDB0971K:
http://www2.clst.riken.jp/arg/mutant%20mice%20list.html) was generated as follows: Targeting gene sequences were isolated from a C57BL/6J
BAC library (BACPAC) by a homologous recombination approach 
| Immunohistochemistry staining
Perfusion fixation was performed under isoflurane anesthesia, and removed brains were immediately immersed in 4% paraformaldehyde in PBS at 4 C overnight, followed by paraffin embedding. 
| Cuprizone-induced demyelination and microcomputed tomography (micro-CT)
Demyelination was induced in 2-month-old male mice by feeding powdered mouse chow containing 0.2% cuprizone (cat no. C9012, Sigma-Aldrich) for 6 weeks, and the normal pellet diet was then reinitiated for the induction of remyelination as described previously Kuboyama et al., 2017) . Regarding micro-CT imaging, mouse brains were fixed with 4% paraformaldehyde and immersed in a graded series of Histodenz (cat no. D2158, SigmaAldrich) solutions. Specimens were scanned on the micro-CT system R_mCT2 (Rigaku, Tokyo, Japan) at 90 kV (160 μA) with a 20-mm field of view, and data were reconstructed using OsiriX software (OsiriX Medical Imaging Software, RRID:SCR_013618). CT numbers were recorded from two regions of interest (four adjacent pixels each) in the dorsal corpus callosum and cerebral cortex for each image.
| Image and statistical analyses
Quantitative image analyses were performed using Adobe Photoshop . Under TH-induced differentiation conditions, we treated OL1 cells for 1 hr with or without PTN and estimated increases in the tyrosine phosphorylation levels of the substrates and substrate candidates of PTPRZ, because the tyrosine phosphorylation of PTPRZ substrates peaks approximately 30 to 60 min after the PTN stimulation . The PTN treatment increased the tyrosine phosphorylation of AFAP1L2, paxillin, ERBB4, GIT1, p190RhoGAP, and NYAP2 in a descending order; however, marked changes were not detected in MAGI1, TJP2, or MAGI2 ( Figure 1a ). The tyrosine phosphorylation of UBR3 was not detectable by Western blotting. Among the molecules that showed elevated tyrosine phosphorylation, paxillin (Fujikawa et al., 2011) , ERBB4 (Fujikawa et al., 2007) , GIT1 (Fujikawa et al., 2011; Kawachi et al., 2001) , and p190RhoGAP (Tamura et al., 2006) have already been verified as physiological PTPRZ substrates.
The tyrosine phosphorylation of p190RhoGAP in OPCs was previously shown to be regulated by FYN (Liang, Draghi, & Resh, 2004) and PTPRZ (Kuboyama et al., 2012) ; however, PTN did not affect the tyrosine phosphorylation of FYN ( Figure 1a , two lanes at the bottom).
Changes in the overall tyrosine phosphorylation pattern in cellular proteins were not detected (Figure 1b ). Taken together with the finding that the PTN-induced enhancement of OPC differentiation was not observed in Ptprz-deficient primary glial cells , these results supported PTN-induced increases in the phosphorylation of these proteins being due to the inactivation of PTPRZ, but not the activation of FYN.
| AFAP1L2-mediated coupling of the PTN-PTPRZ signal to the PI3K-AKT pathway
We focused on AFAP1L2 in the present study because it showed the most prominent increase in PTN-induced tyrosine phosphorylation. Anti-FLAG immunoprecipitation showed that AFAP1L2 stably associated with wild-type Z-ICR (Figure 2d ). However, the DA substratetrapping mutant of Z-ICR (Kawachi et al., 2001 ) exhibited a significantly higher binding ability than the wild type, suggesting that the ability of PTPRZ to recognize AFAP1L2 as a substrate depends on at least two factors: phospho-Tyr recognition in the substrate protein by the catalytic domain and another undefined recognition mechanism between AFAP1L2 and the ICR of PTPRZ. Regarding the latter, PTPRZ is known to associate with PDZ domain-containing proteins, including MAGI1/3 and PSD95, through the C-terminal PDZ-binding motif in PTPRZ (Fujikawa et al., 2011) . However, the PDZ-binding-motif mutant (SA mutant) of PTPRZ showed no significant difference in its association with AFAP1L2 ( Figure 2d ).
A public database search (PhosphoSitePlus) (Hornbeck et al., 2015) suggested that AFAP1L2 contains 14 potential tyrosine phosphorylation sites (Figure 3a) . We transfected v-src HEK293T cells with an expression plasmid for FLAG-tagged AFAP1L2 F14 , in which all 14 tyrosine residues were replaced with phenylalanine residues, and found that this replacement expectedly resulted in the complete disappearance of tyrosine phosphorylation (compare "F 14 " with "WT" Figure S4 in Figure 3b ). We generated a series of AFAP1L2F 13 -Y mutants, in which individual phenylalanine residues were reconverted to tyrosine residues. Experiments to assess phosphorylation and dephosphorylation at each site using these AFAP1L2 mutants showed that phosphorylation occurred at 13 sites other than Tyr-673 in v-src HEK293T cells (Figure 3b) . Coimmunoprecipitation experiments detected the binding of wild-type and F 13 -Y54 AFAP1L2 to MYCtagged p85α of PI3K, indicating that Tyr-54 is the primary phosphorylation site for its association with p85α ( Figure 3c ). The cotransfection of wild-type PTPRZ-B, but not the CS mutant, significantly reduced the tyrosine phosphorylation levels of the 11 mutants, in which AFAP1L2F 13 -Y54 and -Y56 showed the most prominent decreases (Figure 3d ). Consistently, recombinant PTPRZ proteins more efficiently dephosphorylated AFAP1L2F 13 -Y54 than AFAP1L2F 13 -Y383 in vitro (Supporting Information Figure S1 ), indicating that the SH2 domain-binding motif was indeed the major dephosphorylation site of PTPRZ.
PTN reportedly stimulates the proliferation of several types of cancer cells through other receptors, including ALK (Papadimitriou et al., 2016) . We examined the effects of suppressing AFAP1L2 expression in OL1 cells by siRNA knockdown (Figure 4a ). PTN significantly increased the incorporation of BrdU in OL1 cells; however, this was not affected by the knockdown of AFAP1L2 (Figure 4b ). We cannot exclude the possibility that the increased incorporation of BrdU is attributable to a p53 deficiency in OL1 cells, which were established from p53 knockout mice . PI3K/AKT signaling plays a pivotal role in the suppression of apoptosis in multiple cell types (Hanahan & Weinberg, 2000) . Consistently, the knockdown of were incubated in serum-free medium for 3 hr. Cell extracts were examined using PY20, rabbit anti-PTPRZ-S (for PTPRZ-B proteins), and anti-FLAG (for flag-AFAP1L2 proteins). (b) Tyrosine phosphorylation levels of AFAP1L2. FLAG-tagged AFAP1L2 proteins immunoprecipitated from cell extracts using the anti-FLAG antibody were analyzed using PY20 and anti-AFAP1L2 antibodies. The scatter plot shows the signal intensity of PY20 staining relative to the moc control, in which each circle corresponds to an independent cell culture (n = 6). **, p < .01, significant difference between the indicated groups using a one-way analysis of variance (ANOVA) with Bonferroni's post hoc tests. (c) in vitro dephosphorylation of AFAP1L2 by PTPRZ. FLAGtagged AFAP1L2 proteins purified by immunoprecipitation with anti-FLAG beads were incubated with human PTPRZ-ICR proteins in the presence or absence of SCB4380. Tyrosine phosphorylation levels were examined by Western blotting using PY20 and anti-AFAP1L2
antibodies. The scatter plot shows the signal intensity of PY20 staining relative to the nontreated control, in which each circle corresponds to an independent assay (n = 3). *, p < .05; **, p < .01, significant difference between the indicated groups using a one-way ANOVA with Bonferroni's post hoc tests. (d) Coimmunoprecipitation experiments. EGFP-fused wild-type PTPRZ-ICR (WT), its CS, or Asp-1902 to Ala (DA), or Ser-2314 to Ala (SA) mutant was expressed in v-Src-HEK293T cells with or without FLAG-tagged AFAP1L2. Cell extracts were subjected to immunoprecipitation with an anti-FLAG antibody, and analyzed by Western blotting using anti-GFP and anti-FLAG antibodies. The scatter plot shows the signal intensity of anti-GFP staining, in which each circle corresponds to an independent cell culture (n = 6). *, p < .01, significant difference between the indicated groups using a one-way ANOVA with Bonferroni's post hoc tests. Full-length blots for those that are cropped are shown in Supporting Information Figure S5 After 6 hr of transfection, cells were cultured in differentiation medium with or without PTN for 2 days. Cell proliferation was evaluated by measuring the incorporation of BrdU for the last 12 hr of the culture. Apoptotic cells were stained using the TUNEL method. Scatter plots show the relative levels of BrdU incorporation to the nontreated control group, and the percentage of FITC-labeled TUNEL-positive cells to siRNA-transfected, mCherry-positive cells, in which each circle corresponds to an independent experiment (BrdU incorporation, n = 3 each; TUNEL staining, n = 6 each). *, p < .05; **, p < .01, significant difference between the indicated groups using a two-way ANOVA with Bonferroni's post hoc tests. (d,e) Effects of the AFAP1L2 knockdown on AKT and mTOR phosphorylation. After 48 hr of transfection, cells were treated with or without PTN for 1 hr, and the phosphorylation levels of AKT at Ser-473 and amounts of AKT proteins, or the phosphorylation levels of mTOR at Ser-2448 and its protein amounts were analyzed using cell extracts. The scatter plot shows the intensity of pS473 (d) or pS2448 (e) staining relative to the control, in which each circle corresponds to an independent cell culture (n = 6 each). *, p < .05; **, p < .01, significant difference between the indicated groups using a two-way ANOVA with Bonferroni's post hoc tests. (f ) Effects of AFAP1L2 knockdown on OL1 cell differentiation. After cell cultivation in differentiation medium with or without PTN for 10 days, cell differentiation was analyzed by staining with anti-NG2 proteoglycan (oligodendrocyte precursor cells, OPCs; red) and anti-MBP (oligodendrocyte; green) antibodies in conjunction with the DAPI labeling of nuclei (blue). Scale bars, 100 μm. The scatter plot shows the ratio of MBP-positive cells to NG2-positive cells, with each circle corresponding to an independent cell culture (n = 5 each). **, p < .01, significant difference between the indicated groups using a two-way ANOVA with Bonferroni's post hoc tests. Full-length blots for those that are cropped are shown in Supporting Information Figure S7 [Color figure can be viewed at wileyonlinelibrary.com] (Supporting Information Figure S2a 
| Targeted phosphatase inactivation of PTPRZ in mice
We previously reported the earlier onset of the expression of MBP, a major protein of the myelin sheath, as well as the earlier initiation of myelination in neonatal brains in Ptprz-deficient (null) mice than in wild-type mice (Kuboyama et al., 2012) . To assess the physiological significance of its PTPase activity, we generated a mouse line with a Cys-1930 to Ser (CS) point mutation in the Ptprz gene (Figure 6a ). CS knock-in mice were backcrossed over 10 generations with C57BL/6J mice. CS knock-in mice were fertile and viable and appeared indistinguishable from wild-type or Ptprzdeficient mice.
Quantitative reverse transcription (RT)-PCR analyses revealed
that the mRNA expression of the three splicing isoforms (Ptprz-A, Ptprz-B, and Ptprz-S) was similar in the brains of wild-type, heterozygous, and homozygous CS mutant mice (Figure 6b ). Consistent with mRNA expression, no significant differences were observed in the Western blot patterns of brain extracts with specific antibodies against PTPRZ (Figure 6c to e). Thus, the CS mutation did not affect the expression profiles of PTPRZ isoforms. The full-length core protein (380 kDa) of PTPRZ-A was hardly detected, as already described (Chow, Fujikawa, Shimizu, Suzuki, & Noda, 2008) , despite significant expression at the mRNA level (see Figure 6b ) (Chow, Fujikawa, Shimizu, Suzuki, & Noda, 2008) : PTPRZ proteins are targets for metalloproteinases (Chow, Fujikawa, Shimizu, Suzuki, & Noda, 2008) and plasmin under physiological conditions, and are proteolytically cleaved into fragments, such as Z A -ECF, Z B -ECF, Z-ECF-100, -90, and -70, in the brain Chow, Fujikawa, Shimizu, Suzuki, & Noda, 2008) .
Immunohistochemical staining and Western blotting analyses revealed that CS knock-in mice as well as Ptprz-deficient mice showed stronger MBP expression in the corpus callosum on P10 than wild-type mice ( Figure 7a,c) ; however, similar levels were reached by P90 (Figure 7b,d ). Similar alterations were found in the protein expression level of the myelin regulatory factor (MYRF also known as MRF or Gm98), a critical transcriptional regulator that is essential for oligodendrocyte maturation and CNS myelination (Bujalka et al., 2013; Emery et al., 2009) (Figure 7e ), while there were no genotypic differences in the expression of OLIG2, a pan-oligodendrocyte lineage marker (Figure 7f ). These results indicated that the regulation of OPC differentiation and myelination by PTPRZ is entirely dependent on its PTPase activity. We then compared the phosphorylation levels of AFAP1L2, AKT, and mTOR among the three mouse groups. Consistent with MBP expression levels, the phosphorylation levels of AFAP1L2, AKT, and mTOR were significantly higher in CS knock-in mice and Ptprz-deficient mice than in wild-type mice on P10 (Figure 8a ), while these genotypic differences disappeared at the adult stage (Figure 8b ). Similar tyrosine phosphorylation patterns were observed in p190RhoGAP (Figure 8a (1 μM) and PTN (100 nM) for 10 days, and their differentiation levels were analyzed by the staining of NG2 and MBP proteins, as in Figure 4e . Scale bars, 100 μm. The scatter plot shows the ratio of MBP-positive cells to NG2-positive cells, in which each circle corresponds to an independent cell culture (n = 5 each). **, p < .01, significant difference between the indicated groups using a two-way ANOVA with Bonferroni's post hoc tests. (b) Effects of LY294002 on AKT phosphorylation. OL1 cells were treated with the indicated combination for 1 hr, and AKT phosphorylation was analyzed, as shown in Figure 4d . The scatter plot shows the intensity of pS473 staining relative to the control, in which each circle corresponds to an independent cell culture (n = 6 each). **, p < .01, significant difference between the indicated groups using a two-way ANOVA with Bonferroni's post hoc tests. Full-length blots for those that are cropped are shown in Supporting Information Figure S8 [Color figure can be viewed at wileyonlinelibrary.com] anhydrase-like domain; FNIII = fibronectin type III domain; TM = transmembrane region; PTP-D1 and -D2 = tyrosine phosphatase domain 1 and 2; Neo = neomycin-resistance gene cassette; DTA = diphteria toxin A gene cassette. (b) mRNA expression of Ptprz isoforms. Ptprz-A, Ptprz-B, and Ptprz-S mRNA levels in mouse brains (wt/wt, homozygous for the wild-type allele; wt/cs, heterozygous; and cs/cs, homozygous for the CS mutant allele) were measured by quantitative RT-PCR. They were normalized to Gapdh expression, and plotted as relative values to wt/wt mice (n = 3 animals per group). (c-e) Protein expression of PTPRZ isoforms. In the brain, the three PTPRZ isoforms (PTPRZ-A, -B, and -S) and their processed derivatives (Z A -ECF and Z B -ECF) are expressed as CSPGs, and the removal of the chondroitin sulfate chains by the chABC treatment beforehand is necessary for resolving their core proteins by SDS-PAGE Chow, Fujikawa, Shimizu, Suzuki, & Noda, 2008) . Western blot analyses of brain extracts treated with (+) or without (−) chABC were performed using anti-PTPRZ-S (c), which recognizes the extracellular region of all three isoforms, and anti-RPTPβ (d), which recognizes the PTP-D2 region. The protein amounts applied were verified by CBB staining (e)
We further examined whether the PTPase of PTPRZ is crucial for recovery from the cuprizone (a copper chelator) model of demyelination, which is induced by cuprizone feeding, because Ptprzdeficient mice show accelerated remyelination after the removal of cuprizone . We performed the same experiments and found that CS knock-in mice showed similar levels for the Figure 7 . legend on next page.
acceleration of remyelination to those of Ptprz-deficient mice ( Figure 9 ).
| DISCUSSION
To identify the downstream targets of the PTN-PTPRZ signal for OPC differentiation, we herein examined the effects of a PTN stimulation on the tyrosine phosphorylation of substrate candidates for PTPRZ using OL1 cells as an OPC model. The results obtained demonstrated that PTN increased tyrosine phosphorylation levels in AFAP1L2, paxillin, ERBB4, GIT1, and NYAP2 as well as p190RhoGAP (Kuboyama et al., 2012; Kuboyama et al., 2015; Kuboyama et al., 2016) . Among these, AFAP1L2 showed the most prominent increase in tyrosine phosphorylation upon the PTN treatment. AFAP1L2 was efficiently dephosphorylated by PTPRZ in vitro and in vivo, and the two proteins coimmunoprecipitated, indicating that AFAP1L2 is a native substrate for PTPRZ. PTN-induced PTPRZ inactivation was connected to the The panels show the Western blotting of the cerebral cortices of WT, KO, and CS mouse brains with the CBB staining of applied proteins. Murine MBP has four isoforms (21.5 to 14 kDa), the expression patterns of which change during development (Boggs, 2006) . All MBP bands detected were quantified in total relative to the WT in each experiment (n = 6 animals per group). **, p < .01, significantly different from the WT group using a one-way ANOVA with Dunnett's post hoc test. (e,f) Western blotting of MYRF proteins (e) and OLIG2 (f ) in WT, KO, and CS mouse brains on postnatal days 10 and 90. MYRF proteins exist as the full-length (~150 kDa) and a truncated cleavage product (~80 kDa) (Bujalka et al., 2013) , and, thus, all MYRF bands detected were quantified in total. The scatter plot shows signal intensities relative to the control, in which each circle represents a relative value to the WT in each experiment (n = 6). **, p < .01, significantly different from the WT group using a one-way ANOVA with Dunnett's post hoc test. Full-length blots for those that are cropped are shown in Supporting Information Figure S9 [Color figure can be viewed at wileyonlinelibrary.com] . Brain extracts prepared from WT, KO, and CS mice were subjected to analyses of overall tyrosine phosphorylation patterns, and the protein amounts of AFAP1L2 and p190RhoGAP (the most-left panels). Phosphorylation levels of AKT and mTOR (the second and third panels from the left) were examined using cell extracts, and the tyrosine phosphorylation levels of AFAP1L2 (third panels from the left) and p190RhoGAP (the most-right panels) were investigated in the immunoprecipitates of brain extracts. Scatter plots show signal intensities normalized to wild-type controls (n = 6 animals per group). *, p < .05; **, p < .01, significantly different from the WT group using a one-way ANOVA with Dunnett's post hoc test. Full-length blots for those that are cropped are shown in Supporting Information Figure S10 activation of the PI3K-AKT-mTOR pathway via AFAP1L2. We further demonstrated that phosphatase-inactive (CS) PTPRZ knock-in mice and (Kuboyama et al., 2012) without affecting the tyrosine phosphorylation of FYN itself (Kuboyama et al., 2012) (Figure 1 ).
We recently reported that PTN-induced PTPRZ inactivation enhanced the tyrosine phosphorylation levels of p190RhoGAP in OL1 cells and promoted the differentiation of OL1 cells , which is consistent with the decrease observed in the level of active RhoA (Supporting Information Figure S2b ).
The effect of PTN on PTPRZ (peaking at 30 to 60 min ; Fukada et al., 2006) is considerably slower than that of epidermal growth factor (EGF) or platelet-derived growth factor (PDGF) on their receptor tyrosine kinases and their substrate molecules (usually peaks at~5 min).
The extracellular portion of PTPRZ is highly modified with negatively charged chondroitin sulfate chains, which prevent PTPRZ from spontaneous clustering (Kuboyama et al., 2016) . The number of chondroitin sulfate chains attached to 6B4 proteoglycan (another name of PTPRZ-S secretary isoform of which structure corresponds to the extracellular portion of PTPRZ-A) was estimated to be 24 chains per core protein molecule (Maeda, Hamanaka, Oohira, & Noda, 1995) . Mouse PTPRZ-A and -S contain 31 potential chondroitin sulfate attachment sites (Ser-FIGURE 9 Remyelination after cuprizone-induced demyelination. Micro-computed tomography (micro-CT) images of cuprizone-treated mouse brains. Mice were fed a cuprizone-containing diet for 6 weeks (0 weeks) to induce demyelination, followed by spontaneous remyelination with the removal of cuprizone from the diet (1, 3, and 5 weeks). Normal mice were maintained on the regular diet. Images show the coronal plane reconstruction of micro-CT scans of the dorsal corpus callosum of Histodenz-immersed brains derived from WT, KO, and CS mice. Scale bars, 1 mm. After feeding the cuprizone-containing diet, differences between CT numbers in the dorsal corpus callosum and cerebral cortex decreased because demyelinated areas showed high penetration of the contrast reagent (compare "normal" vs "0") . Damage gradually recovered after a return to the normal diet (compare "0" vs "1," "3," and "5") . The lower scatter plots show relative differences normalized to the averaged value of normal diet-fed wild-type mice (n = 6 animals per group). Each circle corresponds to the average value of the two regions from an individual mouse. *, p < .05; **, p < .01, significantly different from the WT group using a one-way ANOVA with Dunnett's post hoc test
Gly or Gly-Ser) within the extracellular region. Based on simple calculations, the short receptor PTPRZ-B containing 13 potential sites is expected to be modified with 10 chondroitin sulfate chains per molecule. Accumulated binding of positively charged PTN gradually neutralizes electrostatic repulsion between chondroitin sulfate chains, thereby inducing clustering of PTPRZ receptor isoforms, which leads to the inactivation of its intrinsic PTPase (Kuboyama et al., 2016 ). This appears to be a reason for the slower response to PTN. In our experience, it is difficult to detect the ligand effect of PTN on PTPRZ in some of the commonly used cell lines including HEK293T. We think that this may be due to a distinct sugar modification profile from that in OPCs: The chondroitin sulfate modification of PTPRZ-B is markedly weak in HEK293T (Chow, Fujikawa, Shimizu, Suzuki, & Noda, 2008) . The high affinity binding of positively charged ligands to PTPRZ depends on chondroitin sulfate chains (Maeda et al., 1996; Maeda et al., 1999) and their sulfation patterns: Binding affinity of PTN is strong for chondroitin sulfate-E/D, moderate for chondroitin sulfate-C, and very weak for chondroitin sulfate-A (Maeda et al., 2003) .
PTPRZ preferentially dephosphorylates phosphotyrosine in the consensus motif sequence, E/D-E/D-E/D-X-I/V-pY-X (X is not an acidic residue), in physiologically relevant substrates, such as p190RhoGAP at Tyr-1105, paxillin at Tyr-118, GIT1 at Tyr-554, and MAGI1 at Tyr-373 (Fujikawa et al., 2011) . In the present study, we identified AFAP1L2 as another substrate of PTPRZ essentially involved in the regulation of OPC differentiation. It is important to note that AFAP1L2 was recently identified among the top 50 oligodendrocyte-specific proteins (Sharma et al., 2015) . Nevertheless, its functional roles in oligodendrocytelineage cells have not been examined to date, and no obvious phenotypic differences have been reported between Afap1l2-knockout mice and wild-type littermates (Zhao et al., 2014) . AFAP1L2 contains the amino acid sequence D-E-E-Y(54)-I-Y(56)-M in the N-terminal region, which is well matched to the substrate motif (Fujikawa et al., 2011) .
The phosphorylation at Tyr-54 in the YxxM motif is involved in the association of AFAP1L2 with the p85α of PI3K, which leads to the activation of PI3K-AKT signaling (Lodyga et al., 2009; Yamanaka et al., 2012) . In the present study, we identified phosphorylated Tyr-54 in AFAP1L2 as the primary site for p85α binding (Figure 3c ), and demonstrated that PTPRZ efficiently dephosphorylated AFAP1L2, particularly at Tyr-54 and Tyr-56 (Figure 3d ). Taken together with the finding that the interaction between AFAP1L2 and the p85α regulatory subunit of PI3K was enhanced by c-Src in rat thyroid follicular FRTL-5 cells (Yamanaka et al., 2012) , AFAP1L2-mediated PI3K-AKT signaling in oligodendrocyte-lineage cells is considered to be regulated coordinately by FYN and PTPRZ.
The knockdown of AFAP1L2 increased apoptosis in OL1 cells, whereas PTN did not significantly affect apoptosis (Figure 4c ). The PI3K-AKT-mTOR pathway is known to be involved in OPC differentiation and myelin formation (Cui et al., 2005; Kramer-Albers & White, 2011; Tyler et al., 2009; Yu et al., 2011) . In OL1 cells, the knockdown of AFAP1L2 impaired PTN-induced AKT and mTOR phosphorylations Figure S3 ). PTPRZ-A, FYN, and PTN also reached their expression peaks on P5-10, P10, and P10, respectively (Kramer, Klein, Koch, Boytinck, & Trotter, 1999; Kuboyama et al., 2016) . The expression of PTPRZ-A may prevent OPC differentiation by FYN until~P10, and the blockage of PTPRZ is released by the expression of PTN. Thus, both AFAP1L2 and p190RhoGAP may be key downstream molecules of FYN and PTPRZ that regulate myelination during development.
We previously reported that Ptprz-deficient mice, which lack all three isoforms, exhibited the early onset of myelination in the developing brain and accelerated remyelination after demyelinating lesions (Kuboyama et al., 2012; Kuboyama et al., 2015) . OPC differentiation was shown to be inhibited on CSPG-coated culture dishes (Keough et al., 2016; Kuboyama et al., 2017) , and CSPGs, including aggrecan, versican, and neurocan, are enriched in demyelinating plaques in neurodegenerative diseases, such as multiple sclerosis (MS), and impair remyelination (Lau et al., 2012) . It is important to note that the three PTPRZ isoforms are all CSPGs Chow, Fujikawa, Shimizu, Suzuki, & Noda, 2008; Nishiwaki et al., 1998) . Thus, the inhibitory activity of PTPRZ on OPC differentiation may partly be as a result of the function of chondroitin sulfate chains attached to the core protein of PTPRZ. However, the phenotypes of MBP expression and remyelination observed in phosphatase-inactive CS knock-in mice were similar to those in Ptprzdeficient mice (Figures 7-9) . Furthermore, the tyrosine phosphorylation levels of AFAP1L2 and p190RhoGAP were higher in CS knock-in mice, as well as in Ptprz-deficient mice, than in wild-type mice on P10 Although future studies are needed to examine the roles of other tyrosine phosphorylation-enhanced molecules by the PTN stimulation, we herein summarize their conceivable roles in oligodendrocyte differentiation ( Figure 10 ). Among the substrate molecules for PTPRZ previously identified, PTN-induced tyrosine phosphorylation was detected in GIT1, paxillin, and ERBB4 in OL1 cells (see Figure 1 ). GIT1
functions as a scaffold for MEK1 to activate ERK1/2 in focal adhesions, which regulates cell migration (Yin, Haendeler, Yan, & Berk, 2004; Yin, Zheng, Yan, & Berk, 2005) . Src activates GIT1 and stimulates its association with ERK in focal adhesions. In A7r5 smooth muscle cells, cyclic phosphorylation/dephosphorylation at Tyr-554 in GIT1 (by Src and PTPRZ) is crucial for coordinated cell motility, which is regulated through dynamic interactions between GIT1 and paxillin/Hic-5 .
Paxillin associates with ERK through the Src-mediated phosphorylation of Tyr-118 in paxillin (Ishibe, Joly, Zhu, & Cantley, 2003) , which is the dephosphorylation site by PTPRZ (Fujikawa et al., 2011) . Tyr-118 phosphorylation by Src regulates the hepatocyte growth factor (HGF)-stimulated ERK association, which is critical for HGF-stimulated epithelial morphogenesis, including cell spreading and process branching (Ishibe et al., 2003) . Thus, GIT1 and paxillin may function as scaffold proteins to enhance the MEK-ERK pathway in oligodendrocyte differentiation.
Previous studies suggested that the neureglin1 (NRG1)-ERBB4 signal prevents apoptosis and enhances the survival of OPCs during differentiation (Colognato et al., 2004; Nave & Salzer, 2006) . Axonally bound or secreted NRG1 binds to ERBB, and promotes OPC survival by activating the PI3K-AKT pathway (Mitew et al., 2014) . However, in the presence of laminins on myelinating axon tracts, ERBB receptors associate with α6β1 integrins in the plasma membrane of OPCs and stimulate MAPK-driven differentiation signals (Colognato et al., 2004) .
Fyn-depleted oligodendrocytes do not show increases in survival in response to NRG1 (Colognato et al., 2004) , indicating that the survival signal driven by laminin and NRG requires FYN. Previous studies reported that PTN and its family member, midkine, bound to integrins (Mikelis, Sfaelou, Koutsioumpa, Kieffer, & Papadimitriou, 2009; Muramatsu et al., 2004) , and midkine promoted the complex formation of PTPRZ with α6β1 or α4β1 integrins (Muramatsu et al., 2004) . PTPRZ/Integrin/ERBB4 may form multiple receptor complexes during OPC differentiation.
Although there is currently no evidence to show the dephosphorylation of NYAP2 by PTPRZ, this may also be important. NYAP2 is a member of a Neuronal Tyrosine-phosphorylated Adaptor for the PI3K family (NYAP), which is predominantly expressed in neurons (Yokoyama et al., 2011) ; almost no expression was observed in rat CG4 oligodendrocyte cells, whereas NYAP2 was expressed in mouse oligodendrocyte-lineage OL1 cells. Of note, tyrosine phosphorylation was enhanced by PTN (Figure 1 ), NYAPs are tyrosine-phosphorylated by FYN, phosphorylated NYAPs interact with the p85 subunit of PI3K
and activate PI3K, and this links PI3K signaling to the WAVE1 complex (Yokoyama et al., 2011) . Future studies are needed to establish whether NYAP2 has similar functions to AFAP1L2.
In conclusion, PTN-induced PTPRZ inactivation regulates multiple signaling pathways, together with FYN kinase, as a hub molecule that is essential for oligodendrocyte differentiation and myelination. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare that they have no conflicts of interest.
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